Browsing Category

64837 posts
The POPCORN taste of Corn Thins® Crispbreads is now available in Minis

The POPCORN taste of Corn Thins® Crispbreads is now available in Minis

SYDNEY, March 4, 2024 /PRNewswire/ — Experience the crunchy bite-size goodness of…
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease

Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease

–       CBL-514 is the first and only drug to receive both Orphan…
A Portable Robot life Companion: UGREEN Unveils Nexode RG 65W Charger in Malaysia and Singapore

A Portable Robot life Companion: UGREEN Unveils Nexode RG 65W Charger in Malaysia and Singapore

SHENZHEN, China, March 3, 2024 /PRNewswire/ — UGREEN, a global leader in…
CP Foods Implements SMART Internal Auditors for Improved Food Safety

CP Foods Implements SMART Internal Auditors for Improved Food Safety

CP Foods has launched the Smart Internal Auditors program to enhance trust…
PTT is listed in the world’s most valuable brand in 2024, the only one in Thailand, for 12 consecutive years

PTT is listed in the world’s most valuable brand in 2024, the only one in Thailand, for 12 consecutive years

PTT Public Company Limited is the only Thai brand in Brand Finance’s top 500 most valuable brands, with a value of $8 billion.
Quick View: Envision Energy’s Collaboration With International Drugmakers In Mainland China Will Advance Sustainability In The Sector

Quick View: Envision Energy’s Collaboration With International Drugmakers In Mainland China Will Advance Sustainability In The Sector

The Latest: On January 18 2024, AstraZeneca, Lonza, Novartis, Novo Nordisk and…
Sinotruk leaping forward to become world-class technology enterprise

Sinotruk leaping forward to become world-class technology enterprise

JINAN, China, March 2, 2024 /PRNewswire/ — On March 2, SinoTruk’s Science and Technology…
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2

Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2

FORT LEE, N.J., March 2, 2024 /PRNewswire/ — Mezzion Pharmaceuticals is a…